Rockwell Medical Inc. (RMTI)
RMTI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.85
+3.70% on the day
Market cap
$31.6M
Nano cap
Revenue · 2025
$69.3M
No prior year to compare
Net income · 2025
-$5.3M
-7.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/0001628280-26-021186-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | RMTI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 1998 |
| SEC CIK | 0001041024 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $69.3M |
| Net income | -$5.3M |
| Operating income | -$4.7M |
| Net margin | -7.7% |
| Operating margin | -6.8% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $10.7M |
| Total assets | $57.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2024-11-13 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-08-13 |
| Latest proxy | DEFA14A | 2026-05-11 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ATNM | Actinium Pharmaceuticals Inc. (Delaware) | $0.9995 | -5.71% | $31.4M |
| BCTX | BriaCell Therapeutics Corp. Common Shares | $3.71 | -4.13% | $32.3M |
| CPHI | China Pharma Holdings Inc. | $0.7514 | -13.53% | $32.3M |
| GRDX | GridAI Technologies Corp. | $4.55 | -2.36% | $32.4M |
| JAGX | Jaguar Health Inc. | $4.16 | -10.35% | $32.5M |
| NNVC | NanoViricides Inc. | $1.32 | +3.13% | $33.7M |
| IBO | Impact BioMedical Inc. | $3.98 | -1.24% | $34.0M |
| CRVO | CervoMed Inc. | $2.27 | -9.56% | $34.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier